Literature DB >> 8832189

Outcome assessment in epilepsy: available rating scales for adults and methodological issues pertaining to the development of scales for childhood epilepsy.

H A Carpay1, W F Arts.   

Abstract

During the past decade, several scales have been developed to improve the assessment of outcome in epilepsy. These scales were developed for adults and their reliability, validity and usefulness have been established. However, there is also a need for alternative measures of outcome in childhood epilepsy, especially a measure of seizure severity (SS) and measures pertaining to quality of life (QoL). Four of these adult scales are reviewed and compared to examine their applicability in childhood epilepsy. Two important methodological differences between them are discussed: (a) patient self-report vs. physician-based scales and (b) generic vs. disease-specific instruments. QoL in epilepsy is briefly reviewed. Severity of seizures and severity of side-effects are relatively neglected areas of importance to QoL in epilepsy. The existing instruments for adults are not appropriate for children in their present form. Some specific methodological issues, which are relevant for the development of scales for children with epilepsy, are subsequently discussed. New scales pertaining to physical and psychosocial aspects of QoL in childhood epilepsy are being developed. In the near future, data on their reliability, validity and usefulness will become available. A combination of scales focusing on specific aspects of QoL, including SS and severity of adverse effects, and more traditional clinical data may provide a more complete assessment of outcome in childhood epilepsy.

Entities:  

Mesh:

Year:  1996        PMID: 8832189     DOI: 10.1016/0920-1211(96)00013-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

Review 1.  Severity Assessment in CDKL5 Deficiency Disorder.

Authors:  Scott Demarest; Elia M Pestana-Knight; Heather E Olson; Jenny Downs; Eric D Marsh; Walter E Kaufmann; Carol-Anne Partridge; Helen Leonard; Femida Gwadry-Sridhar; Katheryn Elibri Frame; J Helen Cross; Richard F M Chin; Sumit Parikh; Axel Panzer; Judith Weisenberg; Karen Utley; Amanda Jaksha; Sam Amin; Omar Khwaja; Orrin Devinsky; Jeffery L Neul; Alan K Percy; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-03-27       Impact factor: 3.372

2.  Youth With Epilepsy: Development of a Model of Children's Attitudes Toward Their Condition.

Authors:  Joan K Austin; David W Dunn; Susan M Perkins; Jianzhao Shen
Journal:  Child Health Care       Date:  2006

3.  Adaptation of the Manchester-Minneapolis Quality of Life instrument for use in the UK population.

Authors:  H A Hutchings; P Upton; W-Y Cheung; A Maddocks; C Eiser; J G Williams; I T Russell; S Jackson; M E M Jenney
Journal:  Arch Dis Child       Date:  2007-05-23       Impact factor: 3.791

Review 4.  Health-related quality of life in childhood epilepsy: moving beyond 'seizure control with minimal adverse effects'.

Authors:  Gabriel M Ronen; David L Streiner; Peter Rosenbaum
Journal:  Health Qual Life Outcomes       Date:  2003-08-28       Impact factor: 3.186

5.  UGT2B7 gene polymorphism and linkage disequilibrium in pediatric epileptic patients and their influence on sodium valproate monotherapy: A cohort study.

Authors:  Sachidananda Adiga; Nandit Pb; Usha Adiga; Vijaya Shenoy
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

6.  Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy.

Authors:  N Banawalikar; S Adiga; U Adiga; V Shenoy; S Kumari; P Shetty; S Shetty; K P Sharmila
Journal:  Braz J Med Biol Res       Date:  2021-06-14       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.